Margaret Hamburg, M.D.
Co-president, InterAcademy Partnership
Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
NTI | bio Hosts Congressional Educational Event on Dual-Use Bioscience Oversight
NTI | bio hosted an event on Capitol Hill to discuss how Congress and other key decisionmakers can take action to provide necessary oversight to safeguard biotechnologies, without stifling innovation in the field.
New Study Shows Robust Pandemic Preparedness Strongly Linked to Lower COVID-19 Mortality Rates
New study published in BMJ Global Health finds the pandemic was less deadly in countries that rank high on the Global Health Security Index.
Seventh Annual Next Generation for Biosecurity Competition Open for Applications
NTI | bio, the Next Generation for Global Health Security (GHS) Network, the iGEM Foundation, 80,000 Hours, SynBio Africa, and the Global Health Security Network (GHSN) have launched the seventh Next Generation for Biosecurity Competition.
